Alterity Therapeutics (PRNAD) Net Income (2009 - 2019)

Alterity Therapeutics (PRNAD) has reported Net Income for 5 consecutive years, with -$7.8 million the latest figure, recorded in Q4 2019.

• In Q4 2019, Net Income rose 3.44% year-over-year to -$7.8 million; the TTM figure through Jun 2021 stood at -$7.8 million (up 50.87% YoY), while the FY2025 annual figure was -$7.8 million, up 100.0% from the prior year.
• Net Income came in at -$7.8 million for Q4 2019 at Alterity Therapeutics, up from -$8.1 million in the prior quarter.
• The five-year high for Net Income was -$4.5 million in Q4 2017, with the low at -$8.1 million in Q4 2018.
• Average Net Income over 4 years is -$6.5 million, with a median of -$6.7 million recorded in 2016.
• Across the five-year window, Net Income rose 19.13% in 2017 and plunged 77.45% in 2018, its largest moves.
• Year by year, Net Income stood at -$5.6 million in 2016, then grew by 19.13% to -$4.5 million in 2017, then slumped by 77.45% to -$8.1 million in 2018, then increased by 3.44% to -$7.8 million in 2019.
• According to Business Quant data, Net Income over the past three periods registered -$7.8 million, -$8.1 million, and -$4.5 million for Q4 2019, Q4 2018, and Q4 2017 respectively.